Applied Therapeutics, Inc. Gains 68.82%
Applied Therapeutics, Inc. (APLT:NASDAQ) shot up at $7.85, a gain of 68.8%. On Tue, Sep 17, 2024, APLT:NASDAQ hit a New 2-Week Low of $4.65. The stock got featured on our News Catalysts scanner on Wed, Sep 18, 2024 at 11:16 AM in the 'BIOTECH' category. From Tue, Sep 03, 2024, the stock recorded 30.00% Up Days and 27.27% Green Days
About Applied Therapeutics, Inc. (APLT:NASDAQ)
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.
Top 10 Gainers:
- Odyssey Marine Exploration, Inc. (OMEX:NASDAQ), 182.09%
- Veea Inc. (VEEA:NASDAQ), 131.13%
- Portage Biotech Inc. (PRTG:NASDAQ), 118.76%
- Kubient Inc. (KBNT:NASDAQ), 100%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 68.82%
- XCHG Limited (XCH:NASDAQ), 65.5%
- WEBUY GLOBAL LTD. (WBUY:NASDAQ), 58.88%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 47.5%
- Intuitive Machs Inc Cl A (LUNR:NASDAQ), 38.33%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 35.48%